A Dual-Armed Oncolytic Virus Shows Clinical Efficacy in Advanced Solid Cancers.
Clin Cancer Res
; 30(17): 3649-3651, 2024 Sep 03.
Article
em En
| MEDLINE
| ID: mdl-38935348
ABSTRACT
An oncolytic adenovirus armed with tumor necrosis factor-α and interleukin-2 was tested in patients with advanced solid tumors. Antitumor effects were observed in both treated and non-treated lesions, leading to long-term survival in some patients. This clinical trial shows the potential of oncolytic virotherapy for patients refractory to standard therapies. See related article by Pakola et al., p. 3715.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Adenoviridae
/
Interleucina-2
/
Vírus Oncolíticos
/
Terapia Viral Oncolítica
/
Neoplasias
Limite:
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article